静脉注射替奈普酶成功用于妊娠期急性缺血性卒中。
Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy.
作者信息
Namasivayam Balamurugan, Sengodan Chitra, Mohanasundaram Lavanya, Gounder Sathya Chinna, Sivakumar Madunisha
机构信息
Department of Neurology, SIMS Chellum Hospital, Salem, India.
Department of Obstetrics and Gynecology, SIMS Chellum Hospital, Salem, India.
出版信息
eNeurologicalSci. 2024 Jun 19;36:100510. doi: 10.1016/j.ensci.2024.100510. eCollection 2024 Sep.
Intravenous thrombolysis (IVT) with tenecteplase or alteplase is the standard of care in, patients with Acute Ischemic Stroke (AIS) presenting within 3-4.5 h. However here, are no established guidelines for such treatment during pregnancy. We report a case, of AIS in third trimester of pregnancy successfully treated with Tenecteplase. To the, best of our knowledge, this is the first and only case of acute ischemic stroke in, pregnancy treated with Tenecteplase.
对于在3至4.5小时内就诊的急性缺血性卒中（AIS）患者，使用替奈普酶或阿替普酶进行静脉溶栓（IVT）是标准治疗方法。然而，目前尚无针对孕期此类治疗的既定指南。我们报告了一例在妊娠晚期发生AIS且成功接受替奈普酶治疗的病例。据我们所知，这是首例且唯一一例接受替奈普酶治疗的孕期急性缺血性卒中病例。
Zotero 插件